PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for October 10, 2006 Subscribe to this News Feed    Subscribe to this Podcast Feed
 

Cytodyn Offers Latest Info for Advanced Bird Flu Protection and Biotechnologies for Treating and Preventing Infectious Diseases Such as HIV/AIDS

CytoDyn.com announces its expanded free educational material to cover bird flu info, HIV info, and other information vital to public health.

(PRWEB) October 10, 2006 – As the fear of widespread bird flu disease grows, the need for scientifically advanced medications and information grows more vital. CytoDyn.com responds to this demand by offering the latest expanded educational material to cover bird flu preparation. The site also includes updated information about developments in HIV medication and other infectious disease issues.

cytodyn.jpg

Cytodyn.com has been expanded after CytoDyn, Inc.’s acquisition of a family of DNA plasmids under license from the University of Massachusetts. These plasmids make it possible for CytoDyn, Inc. and its subsidiaries to develop vaccines and other products for bird flu defense.

“By using science as a foundation, our drugs are not developed on the usual trial-and-error basis, which leads other companies to have high failure rates or high toxicity,” says Allen D. Allen, CEO of CytoDyn, Inc.

The best features of CytoDyn.com are the ease of finding research and educational materials including information on AIDS/HIV, avian flu info, and other topics of interest to the public and physicians. The site continues to expand as CytoDyn, Inc. works toward more sophisticated means of bird flu defense and other products in its drug development pipeline. The easy-to-use site now includes the latest news on vaccine development from the company, product information, and more about CytoDyn, Inc.’s vision and management.

“In order to better serve patients and family members concerned with infectious diseases and physicians specializing in infectious diseases, we’ve expanded our educational content after licensing advanced flu vaccine technology from the University of Massachusetts,” says Allen.

CytoDyn.com is one of the best sources of bird flu info, AIDS/HIV educational materials, and other information related to infectious diseases and their treatment. The new expansion of the site follows the acquisition of DNA plasmids used under license from the University of Massachusetts, which will allow CytoDyn, Inc. even better opportunities to develop products to guard against avian flu risks.

About CytoDyn.com:

CytoDyn.com is the Website of CytoDyn, Inc. Based in Santa Fe, New Mexico, CytoDyn, Inc.’s mission is to create and maintain shareholder value by successfully developing first-in-class products to treat and prevent serious human diseases. The company’s stock is publicly traded under the symbol CYDY on the Over The Counter Bulletin Board.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U3F1YS1TaW5nLUhhbGYtRmFsdS1JbnNlLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Corinne Allen
CytoDyn, Inc.
505-988-5520
Email us Here
ATTACHED FILES

Ed Martin, Global Marketing Director and Frank Maresca, CEO of Saratoga Equity
Frank Maresca is a consultant to Cytodyn, Inc.

Corinne Allen Vice President of Business Development and Peggy Pence Phd. CRO

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move